Press Releases
27 August 2008
Ellex FY08 Year End Results
Ellex today announced its financial results for the year ended 30 June 2008.
25 June 2008
Market Update - Position of CEO; Update on Outlook FY08
Ellex advises today that CEO Mr Peter Falzon has ceased employment with the Company with immediate effect.
14 May 2008
Outcome of Routine Tax Audit
Ellex advises today that the Australian Taxation Office (ATO)
routine audit of the Company has been completed with no adjustments required.
2 May 2008
Update on Outlook for FY08 Result
Ellex announced today that due to the difficult economic environment, sales growth and pre-tax earnings for the 2008 financial year are not expected to be as strong as previously advised.
3 March 2008
Ellex Appoints Tony Mitchell as CFO
Ellex announced today the appointment of Tony Mitchell as CFO and company secretary.
26 February 2008
Ellex FY2008 Half Year Results
Ellex announced today its financial results for the half year ended 31 December, 2007
31 January 2008
Update on FY08 First Half Result and Outlook for the Year
Ellex announced today that revenue growth in the first half of the 2008 Financial Year would exceed market guidance of 15% over the comparable period in 2007 with approximately 18% achieved.
28 November 2007
Results of 2007 Annual General Meeting
Ellex announced today the results of resolutions put to the 2007 Annual General Meeting.
23 November 2007
Ellex Appoints Warwick Kitt as a Director of Ellex Australia Pty Ltd
Ellex announced today that Warwick Kitt has joined the Board of Ellex Australia Pty Ltd.
10 November 2007
Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema
Ellex today announced clinical results of an ongoing study for non-thermal Retina Regeneration Therapy (Ellex 2RT™).
1 November 2007
Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO
Ellex today announced that the initial results of treating patients with Retina Regeneration Therapy (Ellex 2RT™) will be presented by Peter Hamilton MD, FRCOph at the annual meeting of the American Academy of Ophthalmology.
15 October 2007
John Marshall and Kevin McGuinness Appointed to Ellex Board
Ellex announced today the appointment of Professor John Marshall and Kevin McGuinness to its board of directors to underpin the growth strategy of the company.
23 August 2007
Ellex FY2007 Year End Results
Ellex today announced its financial results for the year ended 30 June 2007.
02 August 2007
Ellex Appoints VP of U.S. Sales and Announces U.S. Expansion
Ellex announced today that effective September 1, 2007 it has appointed Ms Christin Harris as Vice President of U.S. Sales to lead its sales expansion in the United States.
26 june 2007
Ellex Raises $5.5 Million Through Placement
Ellex announced today that it raised $5.5 million through the placement of 6.5 million ordinary shares at a price of A$0.85 per share.
23 april 2007
ELLEX GAINS US FDA APPROVAL FOR 30XL LASER SLIT LAMP
FDA approval of the 30XL laser slit lamp represents another milestone in Ellex's stated strategy to be the leading brand of lasers to treat glaucoma, cataract and retinal conditions.
05 april 2007
ELLEX ENTERS CHINESE OPHTHALMIC LASER MARKET
Ellex has appointed GT Medical, a division of Guotong Holdings Company Limited as its exclusive distributor in China.
27 february 2007
FIRST HALF FY07 RESULTS
Results confirm that Ellex is gaining market share as a result of investments made in new products and distribution. Revenues grew by 26%, exceeding the estimated market growth rate of 5% per year, to $21.2 million.
Download PDF
14 february 2007
Awarded AusIndustry Grant
Awarded $1.9M AusIndustry Grant to Conduct AMD Laser Research
Download PDF
04 december 2006
ELLEX ACQUIRES INNOVATIVE IMAGING
Ellex announced today that it has acquired Innovative Imaging, Inc., a profitable U.S.-based leader in the design and manufacture of ophthalmic diagnostic ultrasound systems.
Download PDF
02 november 2006
CHAIRMAN'S ADDRESS TO ANNUAL GENERAL MEETING
03 october 2006
ELLEX ESTABLISHES DIRECT SALES CHANNEL IN AUSTRALIA
Ellex commences trading of Ellex Australia Pty Ltd as a direct sales subsidiary that will sell the Ellex range of lasers direct to Australian ophthalmologists.
Download PDF
23 august 2006
FULL YEAR FY2006 RESULTS PRESENTATION
23 august 2006
FULL YEAR FY2006 RESULTS
Ellex returns to profitability on the back of strong revenue growth
Download PDF
21 august 2006
ELLEX TO ACQUIRE COHERENT LASERS AUSTRALIA
Ellex to market its ophthalmic lasers directly to ophthalmologists in Australia, New Zealand and the South Pacific
Download PDF
25 july 2006
ELLEX APPOINTS US LASER INDUSTRY VETERAN AS VP OPERATIONS
Herbert Pummer PhD, an accomplished laser industry veteran, appointed as Vice President of Operations
Download PDF
05 june 2006
ELLEX APPOINTS FIRST DIRECT SALESPERSON IN US
Ellex moves to direct sales in US with the appointment of Timothy Broome as Senior Territoy Manager.
Download PDF
27 april 2006
ELLEX APPOINTS NEW POSITION OF CHIEF OPERATING OFFICER
Kevin McGuinness appointed to the new position of Chief Operating Officer (COO).
Download PDF
11 april 2006
ELLEX RECEIVES FDA CLEARANCE FOR RED/GREEN PHOTOCOAGULATOR
Integre Duo, the industry's first solid-state red/green photocoagulator, receives 510(k) clearance
Download PDF
30 march 2006
Ellex TO PRESENT AT CITIGROUP MICROCAP CONFERENCE
18 march 2006
Ellex Introduces New Retina Laser at the ASCRS Annual Meeting
Ellex to introduce the Integre Duo, the world’s first solid-state red and green photocoagulator, today at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in San Francisco.
16 march 2006
Ellex Announces Rebranding and Shifts Focus to Direct Marketing of its Ophthalmic Lasers
Global Headquarters, led by CEO, to move to SF Bay Area
01 march 2006
Half Year FY2006 Results Presentation
01 march 2006
First Half FY06 Results
19 january 2006
Ellex Sells Property for $4.43 Million
29 november 2005
Chairman's Address
Ellex Chairman's Introduction to AGM 2005
15 november 2005
AusIndustry Extends Research and Development Grant
AusIndustry has approved an additional grant of $0.4 million
07 november 2005
Impact of Transition to International Financial Reporting Standards (IFRS)
08 september 2005
Preliminary Final Report - 12 Months to 30 June 2005
Ellex Announces FY2005 Results
28 february 2005
Ellex Announces Restructure of Senior Management in line with Corporate Strategy
Ellex Medical today announced that it had restructured the senior management team, reflecting the Company's growth strategy, now in it's second year.
|
Ellex in the Media
A New View on Imaging the Anterior Segment
Ophthalmology Times, August 15 2008
Laser Treatment Shows Promise for Diabetic Macular Edema
Retina Today, July/August 2008
US Evaluation Improves Crystalens Outcomes
Review of Ophthalmology, July 2008
Laser Rejuvenates the Eye by Cleaning Up Bruch's Membrane, Surgeon Says
OSN Super Site, May 2008
New Laser Therapy Quickly Halts Diabetic Maculopathy: 2RT treats disease early & leaves photoreceptors unharmed
Ophthalmology Times Europe, April 2008
Better Iridotomies Prior to ICL Implantation: The Ultra Q laser offers significant advantages
Ophthalmology Management, March 2008
SLT: A New Option for Pseudoexfoliative Glaucoma
Ophthalmology Times Europe, January 2008
Using Laser Therapy for Diabetic Maculopathy and AMD
Ophthalmology Times, November 2007
Give the Doctor What He Needs – Preferably Today
EuroTimes, October 2007
CORRECTING CAPSULAR CONTRACTION AFTER CRYSTALENS IMPLANTATION
Cataract and Refractive Surgery Today, October 2007
SOLID-STATE SYSTEM BRINGS EFFICIENCY TO DUAL WAVELENGTH PHOTOCOAGULATION
Retinal Physician January/February 2007
WHAT'S AHEAD IN 2007, INTEGRE DUO LASER
SLT EFFECTIVE AS BOTH A PRIMARY AND SECONDARY TREATMENT FOR GLAUCOMA
Ophthalmology Times September 11 2006
More Info
SLT A CONSISTENT AND EFFECTIVE TREATMENT
Ophthalmology Times September 11 2006
More Info
ELLEX STEPS OUT OF THE SHADOWS
GLAUCOMA LASER ALLOWS REPEATED TREATMENTS
|
